1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Ovarian Cancer Treatment Drugs Industry Forecasts - China Focus

Ovarian Cancer Treatment Drugs Industry Forecasts - China Focus

  • March 2016
  • -
  • Asia Market Information & Development Company
  • -
  • 91 pages

This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study focuses on industry trends and forecasts with historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.

Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.

Table Of Contents

Ovarian Cancer Treatment Drugs Industry Forecasts - China Focus
TABLE OF CONTENTS



I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview

Ovarian Cancer Treatment Drugs Sales Volume

Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH?RH

Ovarian Cancer Treatment Drugs Import

Chemotherapeutic Drug
Anthracycline Antibiotics
Fluoropyrimidines
Paclitaxel
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH?RH

Pricing Trend




LIST OF TABLES


I. INTRODUCTION

Economic Outlook Summary

II. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Major Producer and Their Market Share
Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification

Chemotherapeutic Drug Major Producer and Their Market Share
Paclitaxel Major Producer and Their Market Share
Fluoropyrimidines Major Producer and Their Market Share
Anthracycline Antibiotics Major Producer and Their Market Share
Platinum Anticancer Drugs Major Producer and Their Market Share
Targeted Therapy Drug Major Producer and Their Market Share
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Therapertic Antibody Major Producer and Their Market Share
Small Molecules Drug Major Producer and Their Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Major Producer and Their Market Share
Anti-estrogens Major Producer and Their Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
LH?RH Major Producer and Their Market Share
Ovarian Cancer Treatment Drugs Import


LIST OF CHARTS


I. INTRODUCTION

Ovarian Cancer Treatment Drugs Sales Volume

II. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Sales Volume and Market Share
Chemotherapeutic Drug Sales Volume by Drugs Classification
Paclitaxel Sales Volume and Market Share
Fluoropyrimidines Sales Volume and Market Share
Anthracycline Antibiotics Sales Volume and Market Share
Platinum Anticancer Drugs Sales Volume and Market Share
Targeted Therapy Drug Sales Volume and Market Share
Targeted Therapy Drug Sales Volume by Drugs Classification
Therapertic Antibody Sales Volume and Market Share
Small Molecules Drug Sales Volume and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share

Endocrine Therapy Drug Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume by Drugs Classification
Anti-estrogens Sales Volume and Market Share
Progesterone Sales Volume and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
LH?RH Sales Volume and Market Share
Ovarian Cancer Treatment Drugs Import
Chemotherapeutic Drug Import and Market Share
Chemotherapeutic Drug Import by Drugs Classification
Paclitaxel Import and Market Share
Anthracycline Antibiotics Import and Market Share
Fluoropyrimidines Import and Market Share
Placlitaxel Anticancer Drugs Import and Market Share
Platinum Anticancer Drugs Import and Market Share
Targeted Therapy Drug Import and Market Share
Targeted Therapy Drug Import by Drugs Classification
Therapertic Antibody Import and Market Share
Small Molecules Drug Import and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
Endocrine Therapy Drug Import and Market Share
Endocrine Therapy Drug Import by Drugs Classification
Anti-estrogens Import and Market Share
Progesterone Import and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
LH?RH Import and Market Share

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.